The Visiting Nurses Association of Kansas City (VNAKC) was recognized by the VNAA as this year’s winner of the “Innovative Partnership Award” for its partnership with Tria Health.
About Tria Health & the VNAKC:
In 2014, an in-home pharmacist grant was submitted with the objective to improve health outcomes by increasing medication education, lowering medication discrepancies and lowering re-hospitalization for Medicare patients with CHF, COPD, Diabetes and those patients taking 8 or more medications. A partnership was developed with UMKC School of Pharmacy to include the in-home pharmacist program as an option in the community rotation for senior level students. Tria Health was contracted by the VNAKC to provide preceptor and pharmacist supervision to the students.
The 2015 MTM and Medication Adherence Innovations Summit was held in Phoenix, AZ. A few of our Tria Health team members attended and have summarized the important insights they gained from the conference.
Medication non-adherence is when a person misses doses or doesn’t take their medications properly 80% of the time.
Important takeaways from the conference were:
- The importance of motivational interviewing. Tria Pharmacists use motivational interviewing to engage and empower patients to make educated decisions about their health care.
- 66% of people don’t know why they take their medication. Without understanding why and how to take their medication, patients don’t always realize the negative impacts to their health when they don’t take their medication the correct way.
- Education is key for increasing medication compliance. Sometimes a patient does not have the ability to understand all the different medication terminology. That is why a pharmacist is so important. Their goal is break down the terminology to help patients better understand and connect with their medicine.
- Behavior change is hard and requires a consistent message. In a high touch model, it takes at least 7 times for a patient to change their behavior.
For information about Tria Health, visit www.triahealth.com.
Connect with Tria Health:
Tria Health’s medication therapy management (MTM) services save you (and your company) money on health care expenses. Here are a few reasons why MTM matters.
1. Most common chronic conditions are managed through medication.
About 80 percent of chronic conditions require the use of medication. Medication helps to control everything from high blood pressure to depression and heart disease to diabetes, but the sheer number of medications prescribed to these patients makes managing their conditions difficult. As more and more people are diagnosed with these conditions, managing the medications used to treat them becomes even more important.
2. People don’t always take medications the way they should be taken.
In fact, almost half of people taking medications don’t take them as prescribed. That can be for a lot of different reasons, including everything from unpleasant side effects to high costs to simply forgetting to take a medication. Tria Pharmacists educate patients so they understand why and how they should be taking their medications.
3. Lack of communication between patients and prescribers can result in poorly coordinated care.
Patients with multiple conditions often have multiple physicians, all of whom prescribe medications, but often without consulting each other. Tria Health fills this gap in care. Whenever our pharmacists make recommendations to patients, they also communicate that information to physicians.
4. Pharmacists know medication best.
Our pharmacists are clinically trained and board certified with specialties such as ambulatory care, pharmacotherapy psychiatry and infectious diseases. They take the time to analyze each patient’s conditions, medication and lifestyle, and give them personalized advice.
5. MTM delivers results.
Tria Health uses real-time pharmacy data to correct medication-related problems and identify cost saving opportunities for immediate returns.
On May 2nd, The Food and Drug Administration (FDA) released a report regarding the use of daily aspirin to prevent a heart attack and stroke. The FDA’s findings may drastically alter how the health care industry utilizes daily aspirin therapy.
A number of patients take a daily aspirin due to the belief that it reduces their risk of having a heart attack or stroke.
“Primary Prevention” – Refers to patients with diabetes, family history of heart disease, high blood pressure and high cholesterol who have an increased risk of heart attacks and stroke and use aspirin as prevention (before either of these events occur).
“Secondary Prevention” – Refers to the use of daily aspirin therapy for patients who have had a heart attack, stroke, or having known coronary artery disease. Secondary prevention use of aspirin has well established benefits and significantly reduces the chance of a second heart attack or stroke.
The FDA has reviewed new data regarding aspirin use for primary prevention and concluded that there is insufficient evidence at this time to support routine use of daily aspirin therapy in these patients.
What does this mean for you?
If you have not had a heart attack, stroke, or have known coronary heart disease and you take a daily aspirin, talk to your physician about the need for continued use of aspirin and weigh the risk versus benefit of prolonged aspirin therapy.
Recent reports of whooping cough outbreaks in Wisconsin and Texas have highlighted the importance of proper vaccination schedules. Whooping cough is a highly contagious disease that can cause serious illness in babies, especially in those who are too young to start their vaccination series. The best way to protect babies against whooping cough is to ensure all persons in contact with baby have been recently vaccinated.
Vaccination Guidelines by Demographic
The Centers for Disease Control recommend that pregnant women receive a one-time dose of Tdap, the whooping cough vaccine, between the 27th and 36th week of EACH pregnancy.
Children and Adults:
For other children and adults, a one-time dose of Tdap is recommended for most people 11 years and older. A repeat vaccination is only necessary for pregnant women.
The current recommendation is for a total of 5 doses of DTaP, one at 2 months, 4 months, 6 months, 15-18 months, and 4-6 years.
Keep you and your family safe by ensuring you all are whooping cough vaccinated.